|
Classification of
Operational momentum intact, chg. Thanks to high demand for air travel and new contract additions, DOC’s Q3 25/26 results (CYQ4) are set to reaffirm the strong fx-adj. momentum from previous quarters. While reported growth figures might look weak at first glance on Operationally, fiscal Q3 should face strong air travel demand, with upbeat October data: higher capacity and better utilization (source: IATA; international Available Seat Kilometres +7.1% yoy, international Passenger Load Factor +0.7pp yoy). Moreover, December is showing the highest growth in scheduled seats this year of +4.7% yoy, a forward-looking activity measure from IATA (also see p. 2), with momentum to stick into next year. This macro-support should benefit DOC’s Within the Group prospects continue to look bright, in light of the ongoing need for airlines to differentiate via DOC’s services, especially for relevant business- and first-class customers. In fact, DOC’s unique focus and solid execution explains the high customer satisfaction (95% renewal rate), which, together with efficient capital management, results in ROCEs >20%. All backed with solid visibility: currently c. 70% of group sales are contract-based until 2030e. DOC’s positioning within this growing market also explains an EPS CAGR of 24% between FY 24/25 and 27/28e (eNuW, €-based), rendering the current PER of 20x appealing. BUY, unchanged PT of € 266, based on DCF. You can download the research here: do-co-ag-2026-01-05-longupdate-en-3c07a For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 ++++++++++ Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, |
||||||||||||||||||
2254100 05.01.2026 CET/CEST